Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
Sven H. Loosen, Maximilian Schulze‐Hagen, Philipp Bruners, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1503-1503
Open Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature
Maria Guarino, Valentina Cossiga, Chiara Becchetti, et al.
Digestive and Liver Disease (2021) Vol. 54, Iss. 8, pp. 997-1006
Open Access | Times Cited: 14
Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma (Review)
Zhu Zeng, Biao Yang, Zhengyin Liao
Oncology Letters (2020)
Open Access | Times Cited: 14
Sarcopenia Predicts Cancer Mortality in Male but Not in Female Patients Undergoing Surgery for Cholangiocellular Carcinoma
Markus S. Jördens, Lisa Heinrichs, Sven H. Loosen, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5359-5359
Open Access | Times Cited: 11
Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
Giulio Vallati, Claudio Trobiani, Leonardo Teodoli, et al.
Biology (2021) Vol. 10, Iss. 8, pp. 728-728
Open Access | Times Cited: 10
Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis
Anrong Wang, Junfeng Li, Changfeng Li, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25237-e25237
Open Access | Times Cited: 1
Ultrasound Evaluation of Sarcopenia in Patients with Hepatocellular Carcinoma: A Faster and Easier Way to Detect Patients at Risk
Giorgio Esposto, Raffaele Borriello, Linda Galasso, et al.
Diagnostics (2024) Vol. 14, Iss. 4, pp. 371-371
Open Access | Times Cited: 1
The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2315-2315
Open Access | Times Cited: 1
Effect of Sarcopenia on Survival and Health-Related Quality of Life in Patients with Hepatocellular Carcinoma after Hepatectomy
Jiawei Hu, Jinhuan Yang, Haitao Yu, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6144-6144
Open Access | Times Cited: 6
CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study
Siwei Yang, Zhiyuan Zhang, Tianhao Su, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 5
What Is the Role of Body Composition Assessment in HCC Management?
Pompilia Radu, Maryam Ebadi, Aldo J. Montaño‐Loza, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5290-5290
Open Access | Times Cited: 4
Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma
Jen-Fu Yang, Wen–Yen Huang, Cheng‐Hsiang Lo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Changes in prognostic factors for patients with hepatocellular carcinoma underwent transarterial chemoembolization with the transition of the time: Child-Pugh class, Albumin-Bilirubin grade, and then
Takumi Kawaguchi, Shigeo Shimose, Sakura Yamamura, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 17, pp. 1045-1045
Open Access | Times Cited: 5
Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
Maximilian Thormann, Franziska Heitmann, Christine March, et al.
Journal of Contemporary Brachytherapy (2022) Vol. 14, Iss. 4, pp. 364-369
Open Access | Times Cited: 3
Treatment opinion of rehabilitation in sarcopenia and cachexia for oncological patients
Dávid Líška, Barbora Stráska
Klinicka onkologie (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 3
Impact of Sarcopenia on Prognosis in Primary Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Single Center Retrospective Study
Yaowei Bai, Jiacheng Liu, Ying Wang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 7, pp. 1837-1847
Open Access
Sarcopenia does not limit overall survival in patients with colorectal liver metastases undergoing interstitial brachytherapy
Maximilian Thormann, Franziska Heitmann, Vanessa Wrobel, et al.
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (2022) Vol. 195, Iss. 03, pp. 217-223
Closed Access | Times Cited: 2
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
Sven H. Loosen, Max Schulze‐Hagen, Mihael Vucur, et al.
JGH Open (2021) Vol. 5, Iss. 3, pp. 356-363
Open Access | Times Cited: 2
CT-Based Skeletal Muscle Loss for Predicting Poor Survival in Patients With Hepatocellular Carcinoma Experiencing Curative Hepatectomy Plus Adjuvant Transarterial Chemoembolization:a Preliminary Retrospective Study
Siwei Yang, Zhiyuan Zhang, Tianhao Su, et al.
Research Square (Research Square) (2022)
Open Access
Significant Muscle Loss After Stereotactic Body Radiotherapy Predicts Worse Survival in Patients with Hepatocellular Carcinoma
Jen-Fu Yang, Wen–Yen Huang, Cheng‐Hsiang Lo, et al.
Research Square (Research Square) (2022)
Open Access
Previous Page - Page 2

Scroll to top